Adjuvant therapy for women with high-risk endometrial carcinoma

Lancet Oncol. 2018 Mar;19(3):268-269. doi: 10.1016/S1470-2045(18)30091-3. Epub 2018 Feb 12.

Authors

Sean C Dowdy¹, Gretchen E Glaser²

Affiliations

¹ Mayo Clinic, Rochester, MN 55905, USA. Electronic address: dowdy.sean@mayo.edu.
² Mayo Clinic, Rochester, MN 55905, USA.

PMID: 29449190
DOI: 10.1016/S1470-2045(18)30091-3

No abstract available

Publication types

Comment

MeSH terms

Chemoradiotherapy, Adjuvant*
Combined Modality Therapy
Endometrial Neoplasms*
Female
Humans